(2021) Blockade of TGF-beta R improves the efficacy of doxorubicin by modulating the tumor cell motility and affecting the immune cells in a melanoma model. Naunyn-Schmiedebergs Archives of Pharmacology. pp. 2309-2322. ISSN 0028-1298